April 10 – 15, 2021 and May 17 – 21, 2021
Presentation Title: Advancing Biomarker Discovery: Enabling improved tumor immunogenomics through a comprehensive approach
Presenter: Travis Yates, PhD
This presentation will cover:
- Predicting patient response to immunotherapies requires a robust and comprehensive approach to tumor immunogenomics.
- By combining highly sensitive, exome-scale DNA and RNA sequencing with advanced analytics, ImmunoID NeXT™ provides a broad view of the tumor and the immune-related components of the tumor microenvironment from a single, limited sample.
- Combination of ImmunoID NeXT and our exome-wide liquid biopsy assay, NeXT Liquid Biopsy, allows for increased exploration of critical areas of tumor biology.